Top Key Companies for Solid Tumor Testing Market: Inviate Corporation, Beijing Genomics Institute (BGI), Laboratory Corporation of American Holdings, NeoGenomics Laboratories, Inc., Bio-Rad Laboratories, Inc., Invivoscribe, Inc., Opko Health, QIAGEN N.V., ASURAGEN, INC., F. Hoffmann-La Roche Ltd., OmniSeq, Abbott Laboratories, Illumina, Inc., Guardant Health.
Global Solid Tumor Testing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Solid Tumor Testing Market Overview And Scope:
The Global Solid Tumor Testing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Solid Tumor Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Solid Tumor Testing Market Segmentation
By Type, Solid Tumor Testing market has been segmented into:
Conventional testing
Non-conventional testing
By Application, Solid Tumor Testing market has been segmented into:
Hospitals
Diagnostic laboratories
Academic and research institutes
Regional Analysis of Solid Tumor Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Solid Tumor Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Solid Tumor Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Solid Tumor Testing market.
Top Key Companies Covered in Solid Tumor Testing market are:
Inviate Corporation
Beijing Genomics Institute (BGI)
Laboratory Corporation of American Holdings
NeoGenomics Laboratories
Inc.
Bio-Rad Laboratories
Inc.
Invivoscribe
Inc.
Opko Health
QIAGEN N.V.
ASURAGEN
INC.
F. Hoffmann-La Roche Ltd.
OmniSeq
Abbott Laboratories
Illumina
Inc.
Guardant Health
Key Questions answered in the Solid Tumor Testing Market Report:
1. What is the expected Solid Tumor Testing Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Solid Tumor Testing Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Solid Tumor Testing Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Solid Tumor Testing Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Solid Tumor Testing companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Solid Tumor Testing Markets?
7. How is the funding and investment landscape in the Solid Tumor Testing Market?
8. Which are the leading consortiums and associations in the Solid Tumor Testing Market, and what is their role in the market?
Research Methodology for Solid Tumor Testing Market Report:
The report presents a detailed assessment of the Solid Tumor Testing Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Solid Tumor Testing Market by Type
5.1 Solid Tumor Testing Market Overview Snapshot and Growth Engine
5.2 Solid Tumor Testing Market Overview
5.3 Conventional testing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Conventional testing: Geographic Segmentation
5.4 Non-conventional testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Non-conventional testing: Geographic Segmentation
Chapter 6: Solid Tumor Testing Market by Application
6.1 Solid Tumor Testing Market Overview Snapshot and Growth Engine
6.2 Solid Tumor Testing Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Diagnostic laboratories
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic laboratories: Geographic Segmentation
6.5 Academic and research institutes
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Academic and research institutes: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Solid Tumor Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Solid Tumor Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Solid Tumor Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 INVIATE CORPORATION
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BEIJING GENOMICS INSTITUTE (BGI)
7.4 LABORATORY CORPORATION OF AMERICAN HOLDINGS
7.5 NEOGENOMICS LABORATORIES
7.6 INC.
7.7 BIO-RAD LABORATORIES
7.8 INC.
7.9 INVIVOSCRIBE
7.10 INC.
7.11 OPKO HEALTH
7.12 QIAGEN N.V.
7.13 ASURAGEN
7.14 INC.
7.15 F. HOFFMANN-LA ROCHE LTD.
7.16 OMNISEQ
7.17 ABBOTT LABORATORIES
7.18 ILLUMINA
7.19 INC.
7.20 GUARDANT HEALTH
Chapter 8: Global Solid Tumor Testing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Conventional testing
8.2.2 Non-conventional testing
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Diagnostic laboratories
8.3.3 Academic and research institutes
Chapter 9: North America Solid Tumor Testing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Conventional testing
9.4.2 Non-conventional testing
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Diagnostic laboratories
9.5.3 Academic and research institutes
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Solid Tumor Testing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Conventional testing
10.4.2 Non-conventional testing
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Diagnostic laboratories
10.5.3 Academic and research institutes
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Solid Tumor Testing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Conventional testing
11.4.2 Non-conventional testing
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Diagnostic laboratories
11.5.3 Academic and research institutes
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Solid Tumor Testing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Conventional testing
12.4.2 Non-conventional testing
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Diagnostic laboratories
12.5.3 Academic and research institutes
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Solid Tumor Testing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Conventional testing
13.4.2 Non-conventional testing
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Diagnostic laboratories
13.5.3 Academic and research institutes
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Solid Tumor Testing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Conventional testing
14.4.2 Non-conventional testing
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Diagnostic laboratories
14.5.3 Academic and research institutes
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Solid Tumor Testing Scope:
|
Report Data
|
Solid Tumor Testing Market
|
|
Solid Tumor Testing Market Size in 2025
|
USD XX million
|
|
Solid Tumor Testing CAGR 2025 - 2032
|
XX%
|
|
Solid Tumor Testing Base Year
|
2024
|
|
Solid Tumor Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Inviate Corporation, Beijing Genomics Institute (BGI), Laboratory Corporation of American Holdings, NeoGenomics Laboratories, Inc., Bio-Rad Laboratories, Inc., Invivoscribe, Inc., Opko Health, QIAGEN N.V., ASURAGEN, INC., F. Hoffmann-La Roche Ltd., OmniSeq, Abbott Laboratories, Illumina, Inc., Guardant Health.
|
|
Key Segments
|
By Type
Conventional testing Non-conventional testing
By Applications
Hospitals Diagnostic laboratories Academic and research institutes
|